NCT04955717View on ClinicalTrials.gov

Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences

NACompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

February 24, 2021

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Chlamydia Trachomatis InfectionNeonatal InfectionPreterm BirthGonorrhea
Interventions
OTHER

Chlamydia trachomatis and Neisseria gonorrhoeae screening using the GeneXpert

Chlamydia trachomatis and Neisseria gonorrhoeae testing using the GeneXpert

Trial Locations (2)

90032

University of Southern California, Los Angeles

Unknown

DHMT Clinics, Gaborone

All Listed Sponsors
collaborator

Botswana Harvard AIDS Institute Partnership

OTHER

collaborator

University of California, San Diego

OTHER

lead

University of Southern California

OTHER

NCT04955717 - Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences | Biotech Hunter | Biotech Hunter